Emergent BioSolutions, Inc. (EBS)
12.16
-0.06
(-0.49%)
USD |
NYSE |
Dec 30, 16:00
12.03
-0.13
(-1.07%)
Pre-Market: 20:00
Emergent BioSolutions Market Cap: 638.64M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Black Diamond Therapeutics, Inc. | 141.87M |
| NovaBay Pharmaceuticals, Inc. | 781.27M |
| Palatin Technologies, Inc. | 13.47M |
| Theriva Biologics, Inc. | 6.613M |
| Oragenics, Inc. | 0.6208M |
Market Cap Related Metrics
| PE Ratio | 9.397 |
| PS Ratio | 0.8562 |
| Price to Book Value | 1.096 |
| Price to Free Cash Flow | 482.49 |
| Price | 12.16 |
| Earnings Yield | 10.64% |
| Operating PE Ratio | 5.823 |
| Normalized PE Ratio | 9.632 |